Harrow Health Inc. (HROW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Harrow Health Inc.

    NASDAQ: HROW · Real-Time Price · USD
    39.45
    0.58 (1.49%)
    At close: Sep 11, 2025, 3:59 PM
    39.44
    -0.03%
    After-hours: Sep 11, 2025, 06:51 PM EDT

    Harrow Health Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 199.61M 130.19M 88.59M 72.48M
    Cost of Revenue
    		 49.24M 39.64M 25.38M 18.21M
    Gross Profit
    		 150.37M 90.55M 63.21M 54.26M
    Operating Income
    		 8.82M 431K 1.92M 1.61M
    Interest Income
    		 n/a n/a n/a 5.44M
    Pretax Income
    		 -17.32M -23.71M -14.01M -17.87M
    Net Income
    		 -17.48M -24.41M -14.09M -18.01M
    Selling & General & Admin
    		 129.06M 83.09M 58.24M 41.31M
    Research & Development
    		 12.23M 6.65M 3.05M 11.08M
    Other Expenses
    		 722K 380K n/a n/a
    Operating Expenses
    		 142.02M 90.12M 61.29M 52.4M
    Interest Expense
    		 22.79M 21.32M 7.24M 5.44M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 190.79M 129.76M 86.68M 70.61M
    Income Tax Expense
    		 161K 701K 75K 133K
    Shares Outstanding (Basic)
    		 35.65M 32.62M 27.46M 26.76M
    Shares Outstanding (Diluted)
    		 35.65M 32.62M 27.46M 26.76M
    EPS (Basic)
    		 -0.49 -0.75 -0.51 -0.69
    EPS (Diluted)
    		 -0.49 -0.75 -0.51 -0.69
    EBITDA
    		 19.28M 9.72M -3.1M 4.26M
    EBIT
    		 4.74M -2.62M -6.77M 1.86M
    Depreciation & Amortization
    		 14.54M 12.34M 3.67M 2.4M

    Add to Watchlist